National Medication Error Data
Contents |
Drug Event AlgorithmRecommendations / StatementsFor Consumers Types of Medication Errors The Council realized the need for a standardized categorization of errors. On July 16, 1996, the NCC MERP adopted a Medication Error Index that classifies an error medication errors statistics 2015 according to the severity of the outcome. It is hoped that the medication error classification index will help health care practitioners and institutions to track medication errors in a consistent, systematic manner. The medication error statistics index considers factors such as whether the error reached the patient and, if the patient was harmed, and to what degree. The Council encourages the use of the index in
Medication Errors Articles
all health care delivery settings and by researchers and vendors of medication error tracking software. The ISMP Medication Errors Reporting Program has implemented this index for use in its database. Medication Error Index NCC MERP Index for Categorizing Medication ErrorsColor / Black & White (Requires Acrobat Reader 4.0) NCC MERP Index for Categorizing Medication Errors AlgorithmColor / Black & White (Requires medication errors statistics 2014 Acrobat Reader 4.0) Reference: Hartwig, S.C., Denger, S.D., & Schneider, P.J. (1991) Severity-indexed, incident report-based medication error-reporting program. Am J Hosp Pharm, 48. 2611-2616 Adopted:July 16, 1996Revised:February 20, 2001 NAN Alert The National Alert Network (NAN) publishes the alerts from the National Medication Errors Reporting Program. NAN encourages the sharing and reporting of medication errors, so that lessons learned can be used to increase the safety of the medication use system. September 15, 2016 Observe for possible fluid leakage when preparing parenteral syringes Subscribe Archive Popular links Definition Taxonomy Dangerous Abbreviations Upcoming Meetings There is no meeting avaiable. Previous Meetings Report Medication ErrorsISMP Medication Errors Reporting Program (MERP) Go U.S. Food and Drug Administration's MedWatch Reporting Program © 2016 National Coordinating Council for Medication Error Reporting and Prevention. All Rights Reserved. *Permission is hereby granted to reproduce information contained herein provided that such reproduction shall not modify the text and shall include the copyright notice appearing on the pages from which it was copied. This copyright statement will change to the new year after the 1st of every year.
Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Drugs Home Drugs Drug Safety and Availability Medication types of medication errors Errors Medication Errors Related to Drugs Share Tweet Linkedin Pin it More sharing options
Medication Errors In Hospitals
Linkedin Pin it Email Print Within the Center for Drug Evaluation and Research (CDER), the Division of Medication Error Prevention
Examples Of Medication Errors
and Analysis (DMEPA) reviews medication error reports on marketed human drugs including prescription drugs, generic drugs, and over-the-counter drugs. DMEPA uses the National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) definition of http://www.nccmerp.org/types-medication-errors a medication error. Specifically, a medication error is "any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing; order communication; product labeling, packaging, and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; http://www.fda.gov/drugs/drugsafety/medicationerrors/ and use."DMEPA includes a medication error prevention program staffed with healthcare professionals. Among their many duties, program staff review medication error reports sent to MedWatch, evaluate causality, and analyze the data to provide solutions to reduce the risk of medication errors to industry and others at FDA.Additionally, DMEPA prospectively reviews proprietary names, labeling, packaging, and product design prior to drug approval to help prevent medication errors.Although DMEPA encourages manufacturers to perform their due diligence when naming their drug products and we strive to avoid approving confusing proprietary names for drug products, there are cases of adverse events where a name of a marketed product is identified as a source of confusion and error. Therefore, we continue to encourage healthcare providers, patients and consumers to report all medication errors to MedWatch so that we can be made aware of potential problems related to drug names and the Agency can provide effective interventions that will minimize further errors. In some situations, changing a proprietary name while the product is marketed may be necessary to address safety issues resulting from the name confusion errors.DMEPA also works closely with federal partners, patient safety organizations such as Institute for Safe Medication Practices (ISMP), standard setting
Safety Environment and Facilities Magazine Current Issue Subscriber Services Archives Resources All Resources Webinars Videos Whitepapers Forms & Tools Events Career Center Forums About Mission Statement Editorial Advisory Board Authors Partners http://www.psqh.com/analysis/data-trends-july-august-2009/ Sponsorship Contact Privacy Policy Analyses Uncategorized Data Trends: High-Alert Medications: Error Prevalence and Severity July 14, 2009 ‐ Patton McGinley July / August 2009 Data Trends High-Alert Medications: Error Prevalence and Severity By Ali Rashidee, MD, MS; Juliana Hart, BSN, MPH, CPHQ; Jack Chen, MS;Sanjaya Kumar, MD, MSc, MPH Use of medications is the most common patient treatment intervention medication error in healthcare. It is also the most common source of adverse events in the inpatient setting (Leape et al., 1991). Adverse events from medication usage increase morbidity and mortality as well as the overall cost of care. Based on a rate of 400,000 adverse drug events per year in hospitalized patients, the Institute of Medicine (IOM) Committee estimated that adverse medication errors statistics drug events (ADEs) accounted for $3.5 billion (in 2006 dollars) of additional hospital incurred costs (Institute of Medicine, 2007). Medication errors are defined by the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) as: Any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the healthcare professional, patient, or consumer. Such events may be related to professional practice, healthcare practice, healthcare products, procedures, and systems, including prescribing; order communication; product labeling, packaging, and nomenclature; compounding; dispensing; distribution; administration; education; monitoring and use (n.d.). All medications used improperly can have an adverse impact on patients, but a subset of drugs has increased potential for significant patient harm due to errors. These medications are commonly known as high-alert medications, a term coined by the Institute of Safe Medication Practices (ISMP). ISMP periodically provides healthcare providers with an updated list of higher-risk medications based on event reports submitted to the MEDMARX National Data Repository and the ISMP Medication Error Reporting program, as well as us
be down. Please try the request again. Your cache administrator is webmaster. Generated Fri, 21 Oct 2016 03:05:54 GMT by s_wx1157 (squid/3.5.20)